Memantine vs Mosunetuzumab

## Memantine vs Mosunetuzumab: Overview

This comparison examines the pharmacological differences between **Memantine** and **Mosunetuzumab**.

## Mechanism of Action

**Memantine**: Non-competitive NMDA receptor antagonist.

## Pharmacokinetics

**Half-life**: Memantine — 60-80 hours; Mosunetuzumab — N/A.

## Chemical Properties

**Molecular Formula**: Memantine — C12H21N; Mosunetuzumab — N/A.

**Molecular Weight**: Memantine — 179.3080 g/mol; Mosunetuzumab — N/A.

**Type**: Memantine — Small molecule; Mosunetuzumab — Antibody.